bone morphogenetic protein receptor type 2
| GO Term | Evidence Code | PMID |
|---|---|---|
| blood vessel development | ||
| osteoblast differentiation | ||
| osteoblast differentiation | ||
| mesoderm formation | ||
| maternal placenta development |
| GO Term | Evidence Code | PMID |
|---|---|---|
| nucleoplasm | ||
| nucleoplasm | ||
| plasma membrane | ||
| plasma membrane | ||
| plasma membrane |
| GO Term | Evidence Code | PMID |
|---|---|---|
| protein serine/threonine kinase activity | ||
| protein serine/threonine kinase activity | ||
| transforming growth factor beta receptor activity | ||
| transforming growth factor beta receptor activity, type I | ||
| transforming growth factor beta receptor activity, type II |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:14557 | primary pulmonary hypertension |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026